OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
September 01, 2014
Biopharma companies seeking to leverage opportunities in African market must adopt the right strategy to achieve success.
August 04, 2014
Biopharma manufacturers must reduce the risk in their complex supply chains
The pharma industry makes slow, but steady moves toward commercial-scale continuous processes for small-molecule API manufacturing.
August 02, 2014
Customers are looking to reduce risk, increase performance, and optimize productivity.
Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.
July 02, 2014
The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.